Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Evusheld

Former vaccines tsar describes ‘open warfare’ within UK government during Covid pandemic

Dame Kate Bingham, who led the vaccine taskforce in 2020, said the clinically vulnerable were deprioritised and goals were not followed

The Guardian - UK

Covid-19 drug Evusheld not recommended for NHS use

The National Institute for Health and Care Excellence (NICE) said there is no clinical evidence that it protects against existing coronavirus variants

Wales Online

FDA revokes authorization for key anti-COVID-19 drug, a blow for vulnerable Americans

The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.

Los Angeles Times

From analysis to the latest developments in health,
read the most diverse news in one place.

COVID drugs: the UK's treatment and prevention options and how vulnerable people are being forgotten

In February 2022, the UK government abandoned its remaining pandemic restrictions in favour of “living with COVID”. This approach relies largely on vaccines protecting people from severe disease.

The Conversation

Vulnerable Covid patients to get ready-to-use antibodies

The Public Health Ministry plans to treat Covid-19 patients at risk of complications with long-acting antibodies (LAAB), according to the Department of Disease Control.

Bangkok Post

New Covid drug could protect 500,000 vulnerable Brits but Government refuses to fund it

Brave schoolboy Max Johnson said the Government should offer vital protection to hundreds of thousands of immuno-compromised people who, like him, could risk being killed by Covid-19

Daily Mirror

COVID prevention medication Evusheld for immunocompromised patients rolls out across north-east Victoria

A medication providing greater protection against COVID-19 for those who are immunocompromised is available across Wangaratta and surrounding areas.

ABC News

Read news from The Economist, FT, and more,
with one subscription

'There can't be different rules': why COVID drugs are sitting in stockpile

Health services should do more to help transplant patients get access to COVID drug Evusheld.

Newcastle Herald

AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable

Pharmaceutical CEO says it’s ‘sad’ that UK has failed to order Evusheld for the immunosuppressed

The Guardian - UK

AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook

AstraZeneca Plc's (NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete the delivery by half year 2022. Core EPS came in at $1.89,…

Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

AstraZeneca's COVID-19 Antibody Provides Protection For At Least Six Months In High-Risk Individuals

AstraZeneca plc (NASDAQ:AZN) shared detailed results from the PROVENT Phase 3 pre-exposure prophylaxis (prevention) trial of Evusheld (tixagevimab and cilgavimab), formerly AZD7442. The data showed that Evusheld reduced the risk of developing symptomatic COVID-19 by 77% in the primary analysis and 83% in the six-month follow-up analysis, compared to placebo. There were no…

Benzinga

Evusheld procurement plan gets CCSA approval

The Centre for Covid-19 Situation Administration (CCSA) has approved a plan to procure a long-acting coronavirus antibody cocktail for people with poor immune systems who cannot be vaccinated.

Bangkok Post

Can evusheld treat Covid-19? An infectious disease expert answers 7 key questions

Infectious disease physician Patrick Jackson of the University of Virginia explains how it works, who’s eligible and why some patients are having difficulties accessing it.

Inverse

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

How does the COVID-19 prevention drug Evusheld work and who should receive it? An infectious disease specialist explains

The U.S. Food and Drug Administration granted emergency use authorization to AstraZeneca’s COVID-19 antibody drug Evusheld on Dec. 8, 2021. Infectious disease physician Patrick Jackson of the University of Virginia explains how it works, who’s eligible and why some patients are having difficulties accessing it.

Salon

Evusheld is becoming hard to find

As immunocompromised people work to get a potentially life saving covid therapy, it's becoming harder to locate

Benzinga

AstraZeneca's COVID-19 Vaccine Expected To Win European Approval This Week: Reuters

European Medicines Agency is expected to approve AstraZeneca Plc's (NASDAQ: AZN) antibody-based COVID-19 vaccine for preventing COVID-19 infections,

Asharq Al-Awsat

AstraZeneca COVID Drug Neutralizes Omicron Sub-Variants in Lab Study

AstraZeneca said on Monday its antibody-based cocktail to prevent and treat COVID-19 retained neutralizing activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study. This is the first data looking at the impact of AstraZeneca's Evusheld treatment on "cousins" of the Omicron variant following…

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

It was already hard to find Evusheld, a COVID prevention therapy. Now it’s even harder

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving COVID-19 therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

The Guardian - UK

AstraZeneca’s Evusheld Covid-prevention drug gets UK approval

Treatment aimed at people who cannot be vaccinated is boost to firm’s coronavirus portfolio

Los Angeles Times

Este tratamiento protegería del COVID a las personas vulnerables. Pero muchos no lo saben

Leanne Cook estaba desanimada pero no se sorprendió cuando las pruebas confirmaron lo que ella y sus médicos habían previsto: incluso después de tres inyecciones de una vacuna, no tenía anticuerpos que la protegieran contra el COVID-19.

Tribune News Service

Llega una nueva opción para proteger a los más vulnerables al COVID, pero no alcanza para todos

SAN DIEGO— A Devan McGirr, de Lemon Grove, no le importó pasar una hora el martes por la mañana sentado en la sala de espera de una clínica dental en Hillcrest después de recibir una inyección difícil de conseguir.

People

Thanakorn Wangboonkongchana

Taweesilp Visanuyothin

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Public Health Ministry

Food and Drug Administration

University of Virginia

101 stories

AstraZeneca Plc

80 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.